1.Protective Effect of Complex EGb on Cerebral Ischemic Damage
Traditional Chinese Drug Research & Clinical Pharmacology 2000;0(05):-
Objective: To study the protective effect of Complex EGb(C-EGb) on cerebral ischemic damage. Methods: SD rat model of middle cerebral artery occlusion(MCAO) was established according to the method described by Zea Longa,et al. The neurological symptoms and brain infarction range in rat models were evaluated. Mouse model of cerebral ischemia-reperfusion was set up by ligating bilateral common carotid arteries and loosening them in 30 minutes. Effects of C-Egb on superoxide dismutase (SOD) activity, blood glutathione peroxidase (GSH-Px) level, catalase activity and plasma malonyl dialdehyde (MDA) content were observed. Results: C-EGb markedly improved the neurological symptoms and reduced the range of cerebral infarction in MCAO rats. It also decreased the inhibition of SOD, GSH-Px and CAT activity and reduced the production of MDA in ischemia-reperfusion mice. Conclusion: C-EGb has protective effect on brain tissue from cerebral ischemic damage and its effect is better than that of EGb and that of the mixture of EGb.
2.Efficacy and safety of levonorgestrel combined with danazol capsules in the treatment of endometriosis patients
Qing WANG ; Jianmiao HU ; Heqing JIA
Chinese Journal of Biochemical Pharmaceutics 2017;37(4):370-372
Objective To evaluate the efficacy and safety of levonorgestrel combined with danazol capsules in the treatment of endometriosis patients.Methods Ninety patients with endometriosis were randomLy divided into experimental group and control group(45 cases).The control group was treated with danazol capsules.The experimental group was treated with levonorgestrel on the basis of the control group.The clinical efficacy and serum CA125,CA199,ovarian function,and ovarian function were observed before and one month and three months after treatment.Adverse reaction rate.Results After three months of treatment,the clinical symptoms of the experimental group were lower than the control group(P<0.05); serum CA125,CA199 levels decreased,compared with the control group,the test group decreased significantly(P<0.05); ovarian function recovery Compared with the control group,the difference was statistically significant(P<0.05).two group compared with the incidence of adverse reactions,the difference was not statistically significant.Conclusion Levonorgestrel danazol capsules treatment of endometriosis Bitter patients than the use of danazol capsules better treatment,higher safety,worthy of clinical application to promote.
3.Clinical observation of intradermal injection for treating cervical-shoulder acute herpes zoster
Bin ZHANG ; Zhuoqiang WANG ; Jianmiao HE
Medical Journal of Chinese People's Liberation Army 1983;0(02):-
Objective To observe the analgesic effects of intradermal injection on the cervical-shoulder lesion areas caused by herpes zoster. Method The clinical data of 40 patients suffered from herpes zoster (distribution of skin lesion: C2~C4) were retrospective analyzed. All the cases were divided into two groups, the 20 patients in group A received routine therapies (administered by antiviral drugs, vitamins and calamine lotion) and 2ml 0.75% bupivacaine as well by intradermal injection. The other 20 patients in group B received routine therapy only. The curative effect was evaluated by visual analogue scale (VAS) and quality of sleep (QS). Results After treatment the scores of VAS and QS declined obviously in group A (P0.05). On the day of treatment the scores of VAS and QS in group A were much lower than in group B (P
4.Breast conserving treatment after neoadjuvant chemotherapy for Ⅱ and Ⅲ stage breast cancer
Jianmiao HE ; Yongdong PU ; Yu WANG
Medical Journal of Chinese People's Liberation Army 2001;0(10):-
Objective To investigate the feasibility of breast conserving surgery after neoadjuvant chemotherapy for Ⅱ and Ⅲ stage breast cancer.Methods Forty-six patients,suffering from Ⅱ and Ⅲ stage breast cancer admitted to 309 Hospital of PLA from Jun.2003 to Dec.2008,and received breast conserving surgery after neoadjuvant chemotherapy,were followed-up.Chemotherapy protocol included intravenous injection of epirubicin 60mg/m2 on day 1 and continuous intravenous infusion of paclitaxel 150 mg/m2 for 3 hours on day 2.The neoadjuvant chemotherapy was repeated every 21 days for 2-4 cycles.Patients eligible for breast conserving therapy received quadrantectomy or wide excision of tumor plus axillary lymph node resection.Evidence of local recurrence and distant metastasis and breast contour were followed up after surgery.Results After neoadjuvant chemotherapy,9 patients showed complete clinical response(CR),37 patients showed partial response(PR).Post-operative pathological examination showed that there were varied degrees of apomorphosis and necrosis of tumor cells,interstitial edema,fibrous hyperplasia,and inflammatory cell infiltration,among them pathological remission was found in 4 cases.The patients were followed up for 8 to 70 months with a mean of 58 months,local recurrence was found in 4 cases distant metastasis was found in 3 patients,and 2 of them died.Assessment of breast contour was carried out in 31 cases 1 year after breast conserving therapy,and excellent results were obtained in 6 cases,good in 18 cases and poor in 7 cases.Conclusions It is safe for patients with Ⅱ-Ⅲ stage breast cancer to receive preoperatively treatment with neoadjuvant chemotherapy.Routine operation,postoperative irradiation and chemotherapy and systemic support are the keys to achieve satisfactory result of breast conserving therapy.
5.The preoperative and postoperative effects of preoperative misoprostol and carboprost methylate placement of methyl methacrylate on patients with submucous myoma of uterus undergoing hysteroscopy
Jianmiao HU ; Chenjie ZHANG ; Qing WANG ; Heqing JIA
Chinese Journal of Biochemical Pharmaceutics 2017;37(6):218-220
Objective To investigate the influence of misoprostol and carboprost methylate for preoperative vaginal placement on the clinical index, the cervical dilatation degree and adverse reactions of patients with submucous myoma of uterus by hysteroscopic surgery.Methods150 patients with submucous myoma of uterus by hysteroscopic surgery were chosen in the period from August 2013 to August 2016 in Yiwu Maternal and Child Health Care Family Planning Service Center and divided into two groups including group A (75 patients) with misoprostol and group B (75 patients) with carboprost methylate for preoperative vaginal placement;and the operation time, the intraoperative blood loss, the recovery time of gastrointestinal function, the effects of cervical dilatation, the width of cervical dilatation and the adverse reactions incidence of both groups were compared.ResultsThe operation time and the intraoperative blood loss of B group were significantly better than A group(P<0.05).There was no significant difference in the recovery time of gastrointestinal function between the two groups.The effects of cervical dilatation in group B were significantly better than that in group A(P<0.05).The width of cervical dilatation in group B were significantly larger than that in group A(P<0.05).There was no significant difference in the adverse effects incidence between the two groups.ConclusionCompared with misoprostol, carboprost methylate for preoperative vaginal placement in the treatment of patients with submucous myoma of uterus by hysteroscopic surgery can efficiently shorten the operation time, reduce the operation bleeding, improve the effect of cervical dilatation and not increase the adverse reactions risk.
6.Effect of long term low dose mifepristone in treatment of uterine leiomyoma
Qing WANG ; Chenxie ZHANG ; Jianmiao HU ; Jiangping SHI ; Heqing JIA
Chinese Journal of Biochemical Pharmaceutics 2017;37(5):371-373
Objective To study the effect of small dose mifepristone in the treatment of uterine fibroids.Methodsfrom January 2013~2015 year in January 100 cases of uterine fibroids were treated in Yiwu Maternal and Child Health Care Family Planning Center as the research object in the course of the study, patients began taking mifepristone in menstruation third days to 5 days, taking a total of 6.5 months, after the observation of its long-term use of low-dose mifepristone after treatment, changes in sex hormone the level of the effect of low-dose mifepristone in the treatment of patients with uterine fibroids and patients in the body, including the effects on the endometrium.The clinical symptoms and signs, the changes of hormone levels and the results of B-ultrasound were followed up.ResultsAll of the 100 patients were treated with low dose mifepristone for a period of time, all of them had amenorrhea.Before treatment, the level of estradiol in patients was (298.5±156) pmol/L, and the level of progesterone (2.8±1.3) was pmol/L.After 6.5 months of treatment, the level of estradiolof the patients was(228.4±114)pmol/L, and the level of progesterone(1.3±0.5)pmol/L was pmol/L.The results showed that the levels of progesterone and estradiol in patients after treatment were significantly lower than those before treatment, with statistical difference (P<0.05).There was no significant change in endometrial thickness after long-term low-dose mifepristone treatment (P>0.05).After treatment, the total effective number of cases was 92 cases, the effective rate was 92%.ConclusionSmall dose of mifepristone for uterine fibroids clinical treatment effect is good, to a large extent, improve the effective rate of treatment and high safety, with the clinical significance of further promotion and application.
7.The role of neoadjuvant chemotherapy and breast-conserving surgery in stage Ⅱ,Ⅲ breast cancer
Jianmiao HE ; Keying CUI ; Yongdong PU ; Yu WANG
Chinese Journal of General Surgery 1994;0(05):-
0.05).Conclusions Neoadjuvant chemotherapy followed by breast-conserving surgery for stage Ⅱ and Ⅲ breast cancer is safe and can achieve the results of radical operation.Neoadjuvant chemotherapy,strict adherence to standerdize surgical technique and use of postoperative radiotherapy and chemotherapy are crucial to breast-conserving therapy for these patients.
8.Perioperative risk factors for postoperative pancreatic fistula in patients with gastric cancer
Huazhou ZHAO ; Ting WANG ; Xinhui ZHANG ; Ruijun LIU ; Zhiyu CAO ; Bo YANG ; Jianmiao HE
Clinical Medicine of China 2016;32(10):924-928
Objective To explore perioperative risk factors for postoperative pancreatic fistu?la. Methods Six hundred and forty?three cases patients who underwent radical gastrectomy for gastric cancer from January 2010 to June 2015 in the NO. 309 Hospital of Chinese People’ s Liberation Army were selected and divided into Postoperative Pancreatic Fistula( POPF) group with 53 cases and Non?Postoperative Pancreatic Fis?tula( NPOPF) group with 590 cases. Preoperative,intraoperative and postoperative data were analyzed by statisti?cal analysis of two groups. Results POPF rate was 8. 24%(53/643). There were no significanct differences in terms of gender,age,preoperation with disease,preoperative serum albumin,TNM stage,abdominal surgery,sur?gical procedure,lymph node dissection,digestive tract reconstruction,surgical approach,blood loss and length of time between the POPF group and NPOP group(P>0. 05). The level of BMI of POPF group was higher than that of NPOPF group,the difference was statistically significant((25. 63±2. 54) kg/m2 vs. (21. 11±2. 44) kg/m2,t=2. 245,P=0. 025). The number of lymph node dissection in POPF group was (32. 25±5. 82),in NPOPF group was (27. 06±6. 79),there was significant difference between the two groups(t=2. 093,P=0. 037). The operation time in POPF group was (242. 50±52. 30) min,in NPOPF group was (229. 51±59. 21) min,the difference was statistically significant between the two groups( t=2. 398,P=0. 017) . The serum CRP of 1 d in POPF group was (85. 72±12. 05) mg/L,in NPOPF group was (76. 41±12. 52) mg/L,and there was significant difference between the two groups( t=1. 979,P=0. 048) . The serum albumin of 2?4 d after operation in POPF group was (26. 0±5. 9) g/L,in NPOPF group was (32. 6±6. 8) g/L,the difference between the two groups was statistically significant(t=-10. 185,P=0. 000). The drainage fluid amylase of 1 and 2 d after operation in POPF group was (2094+1444) U/L,in NPOPF group was (746+486) U/L,and there was significant difference be?tween the two groups( t=10. 400,P=0. 000) . Logistic regression analysis results showed that body mass index ( BMI) ,lymph node dissection number,time of operation,postoperative 1,2 d drainage fluid amylase and serum albumin of 2?4 d after operation were postoperative occurred pancreatic fistula risk factors( OR=1. 972,183. 6, 2. 004,0. 150,9. 809,P>0. 05). Conclusion BMI,number of dissected lymph node,duration of surgery,serum albumin of 2?4 d after operation and postoperative 1,2 d drainage fluid amylase have important clinical values for predicted POPF.
9.Regional perfusion of chemotherapeatic drug combined with total mesorectum excision in the treatment of rectal cancer
Jianmiao HE ; Yu WANG ; Yumin XU ; Shiyan XU ; Youjun WU ; Yongdong PU
Medical Journal of Chinese People's Liberation Army 2001;0(12):-
Objective To evaluate the efficacy of regional perfusion of chemotherapeutic drug in rectal cancer patients who had undergone total mesorectum excision(TME).Methods The therapeutic effects were retrospectively analyzed of 178 rectal carcinoma patients,who were admitted in the hospital from 1999 to 2006,had undergone TME,and then received chemotherapy through various routes.Among them,a catheter was placed in the left internal iliac vein,and chemotherapeutic drug was administered through it postoperatively in 90 patients.The other 88 cases served as control,and they received systemic intra-venous chemotherapy after TME.No significant difference on clinical parameters was evident between the two groups during the course of treatment.The 1,3 and 5 year local recurrence rates,metastasis rates and survival rates of the two groups were compared.Results The 1,3 and 5 year local recurrence rates in the study group were 0,2.5%(2/79) and 3.9%(3/77),respectively,while they were 1.1%(1/88),3.9%(3/77) and 8.1%(6/74),respectively in control group.There was a significant difference in the local recurrence rate between two groups(P
10.The role of regional perfusion and systemic chemotherapy with total mesorectum excision in treatment of rectal cancer
Jianmiao HE ; Yu WANG ; Keying CUI ; Shiyan XU ; Youjun WU ; Yongdong PU
Chinese Journal of General Surgery 1997;0(04):-
Objective To evaluate the role of regional chemotherapy via internal iliac artery pump,systemic chemotherapy and total mesorectum excision(TME) in the treatment of rectal cancer.Methods A total of 193 patients with rectal carcinoma divided into 2 groups: The observation group,included 98 cases who underwent TME,regional chemotherapy through internal iliac artery pump and systemic chemotherapy.The other 95 cases,as control group,were treated with systemic chemotherapy after TME.The local recurrence rate,metastasis rate and survival rate were compared between the two groups.Results The local recurrence rate and metastasis rate of the observation group was significantly lower than that of the control group.The local recurrence rate at 1-,3-and 5-year was significantly lower in the observation group[0,2.5%(2/81) and 3.8%(3/79) respectivvely]than that in the control group [1.1%(1/95),11.4%(9/79) and 16.2%(11/68) respectively](P